NO922795D0 - USE OF 1,4-DIHYDROPYRIDINES IN DIABETES - Google Patents

USE OF 1,4-DIHYDROPYRIDINES IN DIABETES

Info

Publication number
NO922795D0
NO922795D0 NO922795A NO922795A NO922795D0 NO 922795 D0 NO922795 D0 NO 922795D0 NO 922795 A NO922795 A NO 922795A NO 922795 A NO922795 A NO 922795A NO 922795 D0 NO922795 D0 NO 922795D0
Authority
NO
Norway
Prior art keywords
dihydropyridines
diabetes
nimodipine
medicament
calcium
Prior art date
Application number
NO922795A
Other languages
Norwegian (no)
Other versions
NO922795L (en
NO300253B1 (en
Inventor
Joerg Traber
Willem Hendrik Gispen
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of NO922795D0 publication Critical patent/NO922795D0/en
Publication of NO922795L publication Critical patent/NO922795L/en
Publication of NO300253B1 publication Critical patent/NO300253B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of 1,4-dihydropyridines with a calcium-antagonistic action, especially of nimodipine, for the preparation of a medicament for controlling damage to peripheral nerves caused by diabetes.
NO922795A 1991-07-30 1992-07-15 Use of 1,4-dihydropyridines in diabetes NO300253B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125116A DE4125116A1 (en) 1991-07-30 1991-07-30 USE OF 1,4-DIHYDROPYRIDINE IN DIABETES

Publications (3)

Publication Number Publication Date
NO922795D0 true NO922795D0 (en) 1992-07-15
NO922795L NO922795L (en) 1993-02-01
NO300253B1 NO300253B1 (en) 1997-05-05

Family

ID=6437256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922795A NO300253B1 (en) 1991-07-30 1992-07-15 Use of 1,4-dihydropyridines in diabetes

Country Status (19)

Country Link
EP (1) EP0525537B1 (en)
JP (1) JP3381198B2 (en)
KR (1) KR930001908A (en)
AT (1) ATE111732T1 (en)
AU (1) AU659177B2 (en)
CA (1) CA2074709A1 (en)
CZ (1) CZ281712B6 (en)
DE (2) DE4125116A1 (en)
DK (1) DK0525537T3 (en)
ES (1) ES2059181T3 (en)
HU (1) HU208632B (en)
IE (1) IE65109B1 (en)
IL (1) IL102648A (en)
MX (1) MX9204423A (en)
NO (1) NO300253B1 (en)
RU (1) RU2043102C1 (en)
SK (1) SK238692A3 (en)
TW (1) TW202388B (en)
ZA (1) ZA925686B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863360A (en) * 1988-01-15 1989-09-05 Rogers Industrial Products Bag control mechanism for tire press

Also Published As

Publication number Publication date
ES2059181T3 (en) 1994-11-01
RU2043102C1 (en) 1995-09-10
IL102648A (en) 1997-03-18
DE59200530D1 (en) 1994-10-27
JP3381198B2 (en) 2003-02-24
ZA925686B (en) 1993-04-28
KR930001908A (en) 1993-02-22
DE4125116A1 (en) 1993-02-04
NO922795L (en) 1993-02-01
HU208632B (en) 1993-12-28
CA2074709A1 (en) 1993-01-31
MX9204423A (en) 1993-01-01
EP0525537A1 (en) 1993-02-03
DK0525537T3 (en) 1995-02-20
CZ238692A3 (en) 1994-01-19
NO300253B1 (en) 1997-05-05
JPH06157314A (en) 1994-06-03
IE922467A1 (en) 1993-02-10
EP0525537B1 (en) 1994-09-21
AU2048492A (en) 1993-02-04
ATE111732T1 (en) 1994-10-15
HU9202484D0 (en) 1992-10-28
HUT63330A (en) 1993-08-30
IE65109B1 (en) 1995-10-04
SK238692A3 (en) 1995-11-08
AU659177B2 (en) 1995-05-11
CZ281712B6 (en) 1996-12-11
IL102648A0 (en) 1993-01-14
TW202388B (en) 1993-03-21

Similar Documents

Publication Publication Date Title
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
AU6198280A (en) Optically active 1,4-dihydropyridine compound
AU1760988A (en) Enhancers for the transdermal flux of certain 1,4-dihydropyridine derivatives
KR900700569A (en) 2,3-difluorobenzene derivative
NO913136D0 (en) PREPARATION FOR EYE DRAWINGS.
NO890269L (en) PROCEDURE FOR THE PREPARATION OF 1,4-DISUBSTITUTED PIPERIDINYL COMPOUNDS.
DE69221919T2 (en) Piperidine derivatives
AU8212591A (en) Diphenylmethylpiperazine derivative
DE69312776D1 (en) Fungicidal 3,4-diaryl- (5H) -uran-2-one derivative
NO922795D0 (en) USE OF 1,4-DIHYDROPYRIDINES IN DIABETES
DE3882290D1 (en) 2- (SUBSTITUTED IMINO) -1,3,4-DIHYDROTHIADIAZOLE.
FI955829A0 (en) Heterocyclic chemistry
GR3031294T3 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
ATE140228T1 (en) HYDROXYMETHYL-INDOLIZIDINES AND -QUINOLICIDINES
DK142287A (en) OPTIC ACTIVE 1,4-DIHYDROPYRIDINE DERIVATIVES
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
FI890235A (en) Biocidal 4,5-dichloro-1,2-dithiol-3-one composition
CA1262906C (en) 3-(2-furoyl)-5-alkoxycarbonyl-2,6-dimethyl-4- (2-nitrophenyl)-1,4-dihydropyridine calcium antagonists